AGEN•benzinga•
Agenus Inks Partnership Agreement With Zydus Lifesciences To Accelerate Clinical Development, Scale Global Manufacturing, And Expand Patient Access To Botensilimab And Balstilimab For Upfront Consideration Of $75M; Agenus To Receive Up To An Additional $5
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 3, 2025 by benzinga